The Hyderabad-based company's product is bioequivalent to the Organon LLC's Cozaar tablets.
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Topics
Granules India | USFDA | high blood pressure
The Hyderabad-based company's product is bioequivalent to the Organon LLC's Cozaar tablets.
').insertAfter(".article-content__img");$(".article-content__img div").find('div').remove();
Drug firm Granules India on Monday said it has received approval from the US health regulator to market a generic product to treat high blood pressure.
The company has received approval from the US Food & Drug Administration (USFDA) to market Losartan Potassium tablets in strengths of 25 mg, 50 mg, and 100 mg, Granules India said in a regulatory filing.
The Hyderabad-based company's product is bioequivalent to the Organon LLC's Cozaar tablets.
According to IQVIA/IMS Health, the current annual US market for Losartan potassium tablets is around USD 336 million.
Shares of the company were trading 1.24 per cent down at Rs 281.75 apiece on the BSE.
(Only the headline and picture of this report may have been reworked by the Business Standard staff; the rest of the content is auto-generated from a syndicated feed.)
Exclusive Stories, Curated Newsletters, 26 years of Archives, E-paper, and more!
First Published: Mon, February 27 2023. 12:00 IST
JPMorgan has deployed an AI-based research analyst chatbot to enhance productivity among its workforce, with approximate... Read more
Private equity has emerged as a significant force in the global financial landscape, driving substantial growth and inve... Read more
The world’s leading financial stability watchdog has issued a warning about the unresolved vulnerabilities within the ... Read more
In a week marked by strong financial performance, JPMorgan Chase & Co. reported a 25% rise in profits, and US small-... Read more
The financial industry is a competitive landscape where big banks and regional banks vie for market share. Each type of ... Read more
The landscape of philanthropic advisory services provided by private banks has undergone a significant transformation. T... Read more